Ƶ

Agriculture & foodtech Artificial intelligence Health, Wellness & Biotech Startups Venture

The Week’s Biggest Funding Rounds: Another Billion-Dollar AI Raise Leads List That Includes Lots Of Biotech And More AI

Illustration of gardener holding a rake. Venture

Want to keep track of the largest startup funding deals in 2025 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Ƶ Megadeals Board.

This is a weekly feature that runs down the week’s top 10 announced funding rounds in the U.S. Check out the biggest funding rounds of last week here.

This week ended up as a pretty active one for large startup financings. AI and biotech were the biggest areas for funding, led by Grammarly’s $1 billion raise, and a reported $600 million financing for brain implant developer Neuralink.

1. , $1B, artificial intelligence: AI writing and productivity assistant Grammarly secured $1 billion in funding from longtime investor . The San Francisco-based company said it plans to use its new capital, which came from General Catalyst’s Customer Value Fund, “to scale sales and marketing and for strategic acquisitions.”

2. , $600M, neuroscience: Neuralink, the -founded brain implant startup, $600 million in a funding round that sets a $9 billion pre-money valuation. The Fremont, California-based company is currently working on a clinical trial of its brain-computer interface for people with quadriplegia.

3. , $350M, analytics: ClickHouse, a provider of analytics, data warehousing and machine learning technology, $350 million in a Series C financing led by . The Palo Alto-California-based company also secured a $100 million credit facility led by and .

4. , $140M, biotech: New York-based Grin Therapeutics, a developer of therapies to treat serious neurodevelopmental disorders, closed on $140 million in Series D funding. The financing included a $65 million strategic equity investment from and $75 million from existing investor .

5. , $100M, artificial intelligence: Snorkel AI, announced it has raised $100 million in Series D funding at a $1.3 billion valuation. led the financing for the 6-year-old Redwood City, California-based company, which makes tools for evaluation and tuning of specialized AI systems.

6. , $90M, biotech: Indianapolis-based Syndeio Biosciences, a developer of precision neurotherapeutics for central nervous system diseases, this week in conjunction with securing over $90 million from a syndicate of life science investors. Backers include and .

7. , $75M, food and beverage: David, a maker of energy bars in which 75% of calories come from protein, closed a $75 million Series A funding round led by and joined by . The New York company also acquired , a food technology firm offering a plant-based fat alternative.

8. , $72M, bereavement: New York-based Empathy, a provider of support services for managing bereavement and loss, picked up $72 million in a Series C financing led by . The company’s partners include major life insurers, and it says 45 million policyholders across North America are currently able to use its offerings.

9. , $70M, analytics: San Francisco-based Hex Technologies, provider of an AI-enabled analytics platform for data science teams, raised $70 million in Series C funding. Some backers in the round include , , and .

10. , $60M, biotech: Vima Therapeutics, a Cambridge, Massachusetts-based startup focused on oral therapies for movement disorders its launch this week, along with $60 million in Series A financing led by , with participation from and .

Methodology

We tracked the largest announced rounds in the Ƶ database that were raised by U.S.-based companies for the seven-day period of May 24-30. Although most announced rounds are represented in the database, there could be a small time lag as some rounds are reported late in the week.

Illustration:

Stay up to date with recent funding rounds, acquisitions, and more with the Ƶ Daily.

67.1K Followers

CTA

Discover and act on private market opportunities with predictive company intelligence.

Copy link